Ruth A Keri

16PUBLICATIONS
69CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersMolecular targetsCancer geneticsCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Aug 20, 2026
Novel transplantable mouse cell line model recapitulates invasive lobular breast carcinoma (ILC) phenotype and immune microenvironment.

|May 25, 2026
Integrated Collagen Architecture and Composition Improve Risk Stratification in Triple-Negative Breast Cancer.

|Sep 11, 2025
Targeting the ERα DBD-LBD Interface with Mitoxantrone Disrupts Receptor Function through Proteasomal Degradation.

Han Wang, Yuxuan Luo, Sandeep Artham

|Jan 23, 2025
Exploiting YES1-Driven EGFR Expression Improves the Efficacy of EGFR Inhibitors.

Leslie Cuellar-Vite, Elyse M Donaubauer, Kristen L Weber-Bonk

|Jul 22, 2024
Targeting YES1 Disrupts Mitotic Fidelity and Potentiates the Response to Taxanes in Triple-Negative Breast Cancer.

Katrina M Piemonte, Natasha N Ingles, Kristen L Weber-Bonk

|Oct 25, 2023
Spatial Transcriptomics Suggests That Alterations Occur in the Preneoplastic Breast Microenvironment of BRCA1/2 Mutation Carriers.

Anthony Caputo, Kavya Vipparthi, Peter Bazeley

Pageof 3

Frequent Collaborators

5 joint publications

Kristen Weber Bonk

4 joint publications

Darcie Seachrist

3 joint publications

Salendra Singh

3 joint publications

Leslie Cuellar-Vite